Philip Morris
Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
Fields
- Author
- Lee, P.N.
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Named Organization
- Environmental Technology
- Author (Organization)
- Environmental Technology
- Pn Lee Statistics + Computing
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- vic02a00
Document Images
TABLE'4 Reported relative risks of lung cancer in relation to ETS exposure at work.
Study (ref) Sex Index of exposure Relative nsk
(95°k conf.limits)
Garfinkeli (42) Female Smoke exposure at work in last 5 years 0:88C0,66-1.18d
Female Smoke exposure at work in last 25 years 0.93(0:73-1.18)
Kabat 1 (71) Female Current exposure on regular basis to tobacco 0.68(0:32-1.47)
Male smoke at work
Current exposure on regular basis to tobacco
3.27(1.01-10.6)
Kabat2
(72)
Female smoke at work
Exposed to ETS at work (ever)
1.00(0.49-2.06)
Male Exposed to ETS at work (ever) 0.98(0:46-2.10)
Lee (24) Fem ale Passive smoke exposure at work 0.63(0.17-2.33)
Male Passive smoke exposure at work 1.61(0.39-6.60)
Shimizu (73) Female Someone at working place smokes 1.20(0.44-1.37)
Varela (411) Both 150 person/years smoking in the workplace 0:91(0.80,1.04)
Wu (20) Female Passive smoke exposure at work 1.3 (0.5-3.3).
a'IH3;R LSSLJFS
Extension of risk assessments to workplace ETS
and heart disease deaths.
While the use of epid'emiological data to
estimate the number of deaths from lung cancer
among never smokers is dubious, extension of
these estimates to other diseases and to
workplace exposure is even more so. This
highlights the invalidity of the estimates by
Kawachi et a! (6) where of a total of 273 deaths per
year due to ETS among never smokers, only ~Lare
from lung cancer due to at home ETS exposure,
while as many as .j 5?. are from ischaemic heart
disease due to at work ETS exposure., The
fragility of the confidence limits, 112 to 442, for
the overall total of 273 is obvious. In no sense can
we be confident that the true answer lies in this
range. The estimate is cast in an even poorer
light when one realises that the factor of 4 used to
calculate lung cancer relative risks at work from
those at home is also used for heart disease. What
is the justification for that? The basis for the
factor is relative particuliate matter exposure,
widely thought irrelevant to heart disease
aetiology. It is notable that their resultant heart
disease relative risk estimates for at workk
exposure are, implausibly, larger than those
generally reported in relation to actiive smoking.
Extension of risk assessments to exsmokers.
Wells (5)and Repace and Lowrey (7)
estimate numbers of deaths due to ETS among
never smokers and ex-smokers combined. They
assume risk estimates based on results for never
smokers are applicable al'so to~ ex-smokers.
Neither paper discusses the problems implicit in
this approach. In the first place there is no direct
epidemiological evidence on risk in relation to
ETS exposure for ex-smokers with the limited
exception of the study by Varela (41) which found
no evidence of an effect of ETS in either never
smokers or long term ex-smokers. Nor is there
any evidence on levels of ETS exposure in ex-
smokers as distinct from never smokers.
Without direct evidence the assumption that nskk
increases in relation to level of ETS exposure in
ex-smokers to t'he same extent' that it does in
never smokers seems remarkably simplistic.
Might not effects of ex-smoking interact with
those of ETS (if any)? Might not the situation
depend' on how long ago the smoker has given up ,
or why? There seems no scientific justification
whatsoever for extrapolating estimates to ex-
smokers.
Extrapolation from one country to another.
Kawachi er al (6)' do not discuss the validity of
calculating estimates for New Zealand when all
their relevant source data comes from other
countries.. Their answer depends heavily on the
US based factor of 4 used for relative exposure at
work to at home. As noted above a UK study (68,
found' a factor less than 11. Which is relevant for
New Zealand?
Variations in relative risk of lung cancer by age.
As discussed by Wells ('5) and' in the NRC
report by Robins (4'); if the relationship between
?nl

ETS andldng cancer risk depended on age, it
would be appropriate to take this into account in
the ri'sk assessment. In fact only the study of
Hirayama (18; 67) presents data by age, other
investigators implicitly assuming that the
relative risk is invariant of age. Using a relative
risk estimate of 1.44 as applying to all age
groups, Wells calculated there would be 992
deaths per year due to ETS exposure. Wells noted
that Hirayama's data actually indicated "a
declining relative risk with~ age from 1.87 at
approximately age 50 to 1.43 at approximately age
75" and used these data to "develop a second d'eath,
calculation assuming a declining relative risk
but still normalized'to 1.44" arriving at a slightly
lower estimate of 911 deaths per year. Wells"
calculations mislead in a number of ways. First,
he used as source material data an risk by age of
the husband (67) when more appropriate data by
age of the wife were available (18). Second; he
used data for ages 60-69 and 70-79 combined' as
applicable at "approximately age 75", concealing
the fact that the relative risk estimate at age 70-79
is actually 0.70: If one uses data in Wells' Table
6 for never smoker death rates, nonsmoker
populations and4ractions exposed by age, and one
uses Hirayama's actual relative risks by age of
the wife (18), then it can be shown (Table 5) that
allowing for variation in risk by age very
substantially affects estimates. Thus, for the 40-
79 age group; one arrives at an estimate of 858
deaths due to ETS if one assumes age invariance,
but one actually arrives at an estimate of 964
deaths saved by ETS if one uses Hirayama s data
directly. The relative risk estimate for the M79
year age group is certainly unreliable, being
based on only 6 deaths in the Hirayama study (as
against 46, 91 and 57 for ages 40-49, 50-59', 60,69),
so in Table 5 estimates of deaths are also shown
using a combined relative risk for the age groups
60-69 and 70-79. This gives an estimate of 299
deaths due to ETS, substantially less that that
assuming risk is invariant of age. While there
are many problems in applying the Hirayarna
estimates, including the fact that Wells' Table 6
is based on age at death whereas Hirayama s d'ata
are based on age at start of the study Wells' paper
conceals the major problems which have been
given detailed attentiom by a number of authors
(75;, 76). Reliable data broken down by age are
clearly needed.
How many lung cancer deaths are there in total
among never smokers?
In 1985 in the USA, there were a total of 83,854
deaths from lung cancer among males and 38;702
among females (77).In his Tables 6 an& Al,
Wells (5Y gives estimates of death~ rates among
never smokers which, if applied to the age-
specific population estimates of never smokers,
yield 1,907 deaths among males and 4,232 deaths
among females,, respectively 2.3% and 10.9% of
the total deaths from lung cancer.
TABLE 5 Numbers of lung cancer deaths per year among US nonsmokers occurring in the
population aged 40,79 based on Hirayama s (18) estimates of relative risk by age of wife
Risk assumed invariant of age Risk assumed to varyy with age
Age Relative risk Deaths Relative risk' Deaths'
40-44 1.45 32 2.76 69
45-49 1.45 40 2.76 85
50-54 1.45 58 1.72 79
55-59 1.45 89 1.72 122
60-64 1.45 119 11.12( 0.97 ). 39(1-11)
65-69 1.45 165 11.12(0.97) 54(i-15 )
70-74
75-79 1.45
1.45 170
185 0.190.97)
0.19(0.97)) -740(-1:.5)-672(-15).
Total 858 -964(299)
` Bracketed items assume common estimates for 60-69 and 70-79 age group.
Elsewhere C78!1, I have reviewed Uhe respectively,
reasonably
close
to the
proportion of lung cancers occurring among Wells. 0
never smokers in a range of recent Other authors have suggested!there are more or-h
epidemiological studies of Western populations. deaths than this. Thus in the 1986 NRC report: (4' i
This gave an average of 2.4% for males and 13.2% Robins quoted estimates of roughly 5,200 deathss
for females, equivalent to 2,012' and 5,109 deaths for males and 7,000 for femal!es among, U.S.
estimates of ~J
204

never smokers in 1985, while Repaca and Lowrey
(7) cite Kuller et al (36) for an estimate of 6000 to
8000 lung cancer cases each year in US never
smoking women.
Three points arise. First, there is consid-
erable uncertainty about: the number of lung
cancer deaths among never smokers.
Second, if the lower estimates, which total
about 6,000-7,000 deaths in the two sexes
combined; are used, then many of the epidemi-
ologically based estimates shown in Table 2 are
totally unreasonable. Even if (implausibly)
everyone were assumed to be exposed to ETS with
risk doubled as a result the estimated number of
lung cancer deaths occurring among never
smokers would only be 3,000-3,500, and yet the
four highest estimates in Table 2 all exceed this.
Third, none of the estimates of total lung
cancer deaths among never smokers cited above
make any adjustment for miselassification of
smoking status all' taking self-reported smoking
habits at face value. Starting with the first
estimate cited above of 6,139 deaths for the sexes
combined, one can readily calculiate that, if 1% of
ever smokers were assumed to deny smoking on
interview, this figure would fall by over a
thousand to 4,972. This underlines the
unreasonableness of the higher estimates in
Table 2.
DLS(1JSSTON
In the USA in 1985 there were some 120,000 deaths
from lung cancer. Although estimates of the total
number occurnng among never smokers of up to
around 12,000 have been cited, more reasonable
estimates seems to be about 5,000: to 6,000. I!n
attempting to estimate how many of these occur as
a result of ETS exposure, one has to decide
whether to base one's estimate on the
epidemiological evidence on ETS and lung
cancer or on the dosimetric evidence on exposure
to relevant smoke constituents of ETS exposed
nonsmokers and smokers. It is abundantly clear
that the two methods of estimation give very
different answers. Thus, while estimates based
on retained particulate matter give tens of deaths
and those based on nicotine or respirable
suspended particulates give hundreds, the
epidemiologicall'y based estimates all give
thousands of deaths. Which answer, if any, one
accepts depends to a large extent on the faith one
places on the. different types of evid'ence. Wells
(5), Kawaehi~ et al (6) and Repace and Lowrey (7)
accept the epidemiology essentially at face value
and pay little or no attention to its poor quality
and very obvious weaknesses. They either ignore
the dosimetric evidence (6) do not make iit clear
that it gives different answers and/or dismiss it
as inconsistent with the epidemiology (17); or
invoke mechanisms to explain the discrepancy
which are scientifically unappealing (5). It
seems to this author that the epidemiolbgical
evidence is untrustworthy and that, between the
two, the d'osimetnc evidence is preferable_ Of
course problems remain both in choosing the
appropriate index of exposure to use and in
selecting the appropriate dose response curve at
low doses (with the possibility of a threshold), but
it seems clear that this approach is better than one
which leads to such implausibly high figures.
When one restricts attentiom to lung' cancer,
to never smokers and to ETS exposure from the
spouse, one is at least operating in an area where
the epidemiological evidence indicates an
association. When one extends risk assessment
to other diseases, to ex-smokers and to ETS
exposure in the workplace one is stretching the
limits of what is science. There essentially is no
evidence on possible effects of ETS in ex-
smokers and little reason to expect that any
effects, if they exist, will be the same as in never
smokers. There is some evidence on ETS
exposure in the workplace, but this shows no
association at all with Iking cancer risk. The
epidemiological evidence on ETS in relation to
deaths from causes other than lung cancer is
unconvincing, and no scientific authority has
claimed' cause and! effect.
RFT 'FPM1GES
1. International Agency for Research on Cancer. 1ARC Monobr., EraL Coresnog: Risk Che,n:
Hum., 3:8, Tobacco Smoking, I'ARC, Lyon (1986).
2. National Health and Medical Research Council. Report of tho %'orking Partw on the Et1vcts
of Passive Smoking on Health., Australia (11986).
3. US Department of Health and Human Services. The Health Consequences of Inuolontan
Smoking: a Report of the Surgeon General; Rockville (1986).
4. National Research Council. Environmental Tobacco Smoke. .'4fensuring Exposure and
Assessing Health E(fects,, National Academy Press, Washington D!C. (1986):
5. Wells, A.J. Environ. Int., 14, 249-2fi5 (1988):,
I
205

6. Kawachi, I., Pearce, N. and Jackson, R. N:Z. Med J., 102, 337-340 (1989):
7. Repace, J.L. and Lowrey, A.H. Risk Anal., 10, 27-37 (1990):
8. Lee, P.N. A Detailed Review of Epidemiological' Evidence relating Environmental Tobacco
Smoke (ETS) to the Risk o)`Cancer, Heart Disease andOt/ur Causes ojDeath cn Adults who have
Never Smoked. Ih the press.
9. Inoue, R. and Hirayama, T: in Smoking and'Health 1987, Eds. Aoki, M. et a1., Elsevier,.
Amsterd'am, 283-285 (1988).
10. Geng, G.Y., Liang, Z.H., Zhang, A.Y. and Wu, G.L. in Smoking and Health 1987, Eds. Aoki, M.
et al., Elsevier, Amsterdam, 483-486 (1988).
11. Trichopoulbs, D., Kalandidi', A and Sparros, L, The Lancet, 2, 677-678' ('1983)'.
12. Akiba, S., Kato, H. and Blot, WJ. Cancer Res., 46, 4804-4807 (1986):
13. Brownaon, R.C., Reif, J.S.,, Keefe, T.J., Ferguson, S.W. and Pritzl, J.A. Am. J. EpidcmcoG.,
125, 25-34 (1987).
14. Koo, L.C., Ho;,J.H-C., Saw, D. and'Ho, C-Y.Int. J: Cancer,99, 162-169 (1987).
15. Lam, T.H. and Cheng, K.K. in Smoking and' Health 1987, Eds. Aoki, M. et all, Elsevier, 279-
281 (1988):
116. Hole,, D.J., Gillis, C.R., Chopra C. and Hawthorne, V.M. Br. Med. J.,,299, 423-427 (1989).
117. Lam, T.H., Kung, I.T.M., Wong, C.M., Lam; W.K.,, K]eevens; J.W.L, Saw; D., Hsu, C.,
Seneviratne, S., Lam, S.Y., Lo, K.K., and Chan, W.C. Br. J. Cancer, 66, 673-678 (1987):
18. Hirayama, T. in Lung Cancer: Causes and Prevention Eds. Mizell, M. and Correa, P., Verlag
Chemie International Inc., Deerfield Beach, 175-195 (1984).
19. Gao, Y-T., Blot, WJ., Zheng; W., Ershow; A.G., Hsu, C.W., Levin, L.I., Zhang, R. and
Fraumeni, Ji.F. Int: J. Cancer, 40, 604-609 (1987).
20. Wu, A.H., Henderson, B.E., Pike, M.C. and Yu, M.C. J. Nat. Cancer Inst., 74,
747-751 (1985).
21. Correa, P., Pickle, L.W., Fontham, E.,, Lin, Y. and Haenszel, W. The Lancet, 2, 595-59
(1983).
22. Humble, C.G., Samet, JLM. and Pathak, D.R. Am. J. Public Health, 77, 598-602 (1987).
23. Svensson, C., Pershagen, G. and' Klominek, J. Acta Oncol., 28, 623-629 (1989)
24. Lee,, P.N., Chamberlain, J. and Alderson; M.R. Br. J: Cancer, 64, 97-105 (1986)
25. Buffler, P.A., Pickle, L.W., Mason, T.J. and Contant, C. in Lung Cancer Causes and
Prevention, Eds. Mizell, M. and Correa, P: Verlag Chemie International' Inc., fsno-.sFrc)i.rr,,
83-89 (1984).
26. -Chan; W.C. and Fung, S.C. in Cancer Epidemiology, Gustav Fischer Verlag, Vol 6, 199-202
(1982).
27. Lee, P.N. Human To:icol:, 6, 517-524 (1987).
28. Wald, N.J., Nanchahal, K. and Cuckle, H. Br. J. Cancer, 61, 337-344 (11990),
29. Arundel A., Irwin, T. and Sterling, T. J. Environ. Sci. Health, Part C, 4, 93-118 (1986),
30. McAughey, J.J., Pritchard, J.N. and Black, A. in Present and Future o(Indoor Air Quality,
Eds. Bieva, C.J. et al.,, Excerpts Medica International Congress Series 860, Brussels, 161-168
(1989):
31. Adlkofer, F.X., Scherer, G., von Meyerinck, L., von Maltzan, Ch. and Jarczyk, L, in Present
and Future of Indoor Air Quality, Eds. Bieva, CJ. et aL' Excerpta Medica International!
Congress Series 860, Brussels, 189-196 (1989).
32. FongP. J. Biof. Phys., 10, 65-73 (1982). ~
33. Wald, N.J., Nanchahal, K., Thompson S.G: and' Cuckle, H.S. Br. Med. J:, 293, 1217-1222 ~
(1986). N
~
34. Repace, J.L. and Lowrey; A.H. Environ. lnt., 11, 3-22 (1985).
35. Wigle, D., Collishaw, N., Kirkbride, J. and Mao, Y. Can. Med Assoc. J:, 136, 945-951 (1987):~
36. Kuller L.H'., Garfinkel, L., Correa., P., Preston-Martin. S., Haley. N.J., Sandler D:P. and
~
Hoffmann, D. Environ. Health Perspect_70, 57-69 (1986). ~
37. Russell, M.A.H., Jarvis, M.J. and' West, R.J. Br. J. Addict., 81 275-281 (11986). ~
38. Lee, P.N. in Assessment oj' Inhalation F'lazards, Eds. Mohr, U_ et al.,, ILSI Monographs, ~
~
Springer-Verlag, Berlin, 49-59 (1989).
39. Facci,ni, J. Exp.,Pathol., 37, 177-180 (1989):,
40. Begg; C.B. and Berlin, J.A. J: R. Stat. Soc., Ser. A, 151, 419-463 (1988).
206

41. Varela, L.R. 'Aseessment of the Association between Passive Smoking and Lung Cancer. ',
Yale University Doctor of Philosophy Dissertation (i1987)'.
42. Garfinkel, L., Auerbach, 0. and Joubert, L. J. Nat. Cancer Inst.,,75 463-469 (4985):
43. Sobue, T:, Suzuki, R., Nakayama, N.,, Inubuse, C., Matsuda, M., Doi, O:, Mon, T., Furuse. K.,
Fukuoka, M., Yasumitsu, T., Kuwabara, 0., Ichigaya, M., Kurata, M., Kuwabara, M.,,
N'akaharaK., End'o, S. and Hattori, S. Gan No Rinsho, 36, 329-333 (1990).
44. Koo, L.C., Ho, J.H-C. and Rylander, R. Soc. Sci. Med., 26, 751-760 (11988).
4'5. Lee, P.N. Misclbssification of Smoking Habits and' Passiue Smoking. A Review of the
Evidence. Springer-Verlag, Heidelberg, (1988).
46. Saito, R. in Smoking and'Health 1987Eds. Aoki, M. et al., Elsevier, 517-519 (1988):
47. Gillis, C.R:, Hole, D.J., Hawthorne, V, and Boyle, P: Eur. J. Respir. Dis.(Suppl.133), 65, 121-
126 (1984).
48. Garland, C.,, Barrett-Connor E.,Suarez, L.,, Criqui, M.H. and Wingard, D.L. Am. J.
Epidemiol., 121, 645-650 (1985).
49. Helsing, K.J'., Sandier, D.P., Comstock, G.W. and Chee, E: Am. J. Epidemiol:, 127, 915-922
(1988).
50. Svendsen, K.H., Kuller, L.H., Martint M.J. and Ockene, J.K Am. J. Epidemiol., 126, 783'-795
(1987).
~ 51. Martin, M.J., Hunt, S.C: and Williams, R.R. Annual Meeting of American Public Health
Association (1986)~
52. Hrrayama, T. Br. Med. J., 282, 183-185 (1981).
53. Layard, h1.W. and Viren, J.R. in Present and Future of Indoor Air Quality, Eds. Bieva, CJi. et
al. Excerpta Mediea International' Congress Series 860, Btussels 177-180 (1989).
54. Lee, P.N~. Br. Med. J., 283, 1465-1466 (1981).
55. Lee, P.N. (1989) N.Z. Med. J., 102, 539 (1989).
56. Hiravama T. N:Z Med. J., 103, 54 (1990):.
5-1. Garfinkel, L. J. Nat: Cancer Inst., 66, 1061-1066 (11981).
58. Burchi, J.D., Rohan, T.E., Howe, G.R., Risch, H.A., Hil'1 G.B:, Steele, R. and Miller, A.B.
Int. J: Cancer, 44, 622-628 (,1989):
59. Kabat, G.C., Dieck, G.S. and' Wynder, E.L. Cancer, 57, 362-367 (1986):
60. Hellberg, D., Valentin,, J. and Nilsson; S: The Lancet, 2, 1497 (1983).
611. Miller, G:H. West J. Med, 140, 632-635 (1984)_
62. Sandler, D.P., Comstock, G.W., Helsing, K.J. and Shore, D.L. Am. J. Public Health, 79, 163-
167, (1989).
63. Reynold's, P., Kaplan, G..1_ and Cohen, R.D. Society for Epidemiological Research, Amherst
Massachusetts (1987).
64. Slattery, M.L., Robison, L.M., Schuman, K.L., French, T.K.,, Abbott, T.M.,, Overald, J.C. and
Gardner, J.W. JAMA, 261. 1593-1598 ('1989):
65. Layd'e, P.M. JAMA, 261, 1631-1633 (1989).
66. Sandler, D.P., Everson, R.B. and' Wilcox, A.J. Am. J. Epid.emiol., 121, 37-48 (11985)..
67. Hirayama, T. Prev., Med., 13, 680-690 (1984).
68. Caporaso, N.E., Tucker, M.A., Hoover, R.N.,, Hayes, R:B., Pickle, L.W., Issaq,, H.J.,
Muschik,, G.M.,, Green-Gallo, L., Buivys, D., Aisner, S., Resau, J.H.. Trump, B.F., Tollerud,
D., Weston, A. and Harris, C.C. J Nat. Cancer Inst:, 82, 1264-1272 (11990):
69. Sellers, T.A., Bailey-Wilson, J.E., Elston, R.C., Wilson, A.F:, Elston, G.Z., Ooi, W.L. and'
Rothschild, H. J. Nnt, Cancer lnst:, 82, 1272-1279 (1990).
70. FnedmanG.D., Pettiti, D.B. and Bawol, R.D: Ain: J. Public Henlth,73, 401-405 (1983)
711. Kabat, G.C. and' Vr'vnder, E.L. Cancer, 63, 1214-1221 (Q9$4).
72. Kabat, G.C. 19901 Winter Toxicology Forum, W.ashington D.C. (1990).
73. Shimizu, H., ilonshita, M., 1lizumo, K., blasuda, T., Ogura, Y.,,Santo. M.. Nishimura. w1.,
hunishimo. K., liarasawa, Ii., Nishiwaki, K., Yamamoto, M., Hisanichi, S. and Tomonaga, S.
Tohoku J: Exp. Med., 154, 389-397 (1988).
74. Kirk, P.W.W.. Hunter, M., Baek, S.O., Lester, J.N. and Perry;, R. in Ir:door a+id' Ambcent Air
QF,alit.v, Eds. Perry, R. and Kirk, P.W. Selper. Lond'on,, 99-112 (1988),.
75. Ahlborn, W. and L''berla, K. in Indoor and :lmhzent Air Quality. Eds. Perry', R.and I+.irk, P.W.
Selper, Lond'on, 169=1 78(11988):
30'

76. Kilpatrick, SJ. and Viren, J. in Indoor and Ambient Air Quality,, Eds. Perry, R. and F:irk.
P.W., Selper, London, 195-202 (1988).
77. W'orld' Health Organisation. 1988 World Health Statistics Annual, Geneva (1988):
78. Lee, P.N. Udnpublished resullts (1990).
208
